| |
|
- Click on the title
of each paper to access MedLine abstract at NLM site
Vernier-Massouille G, Balde M, Salleron J, Turck D,
Dupas JL, Mouterde O, Merle V, Salomez JL, Branche J,
Marti R, Lerebours E, Cortot A, Gower-Rousseau C,
Colombel JF.
Natural History of Pediatric Crohn's Disease: A Population-Based Cohort Study. Gastroenterology. 2008 Jul 3. Stolfi C, Pellegrini R, Franze E, Pallone F, Monteleone G.Molecular basis of the potential of mesalazine to prevent colorectal cancer. World J Gastroenterol. 2008 Jul 28;14(28):4434-9. Reinisch W, Panés J, Lémann M, Schreiber S, Feagan B, Schmidt S, Sturniolo GC, Mikhailova T, Alexeeva O, Sanna L, Haas T, Korom S, Mayer H.A Multicenter, Randomized, Double-Blind Trial of Everolimus Versus Azathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease. Am J Gastroenterol. 2008 Jul 30. Ananthakrishnan AN, McGinley EL, Binion DG.Inflammatory bowel disease in the elderly is associated with worse outcomes: A national study of hospitalizations. Inflamm Bowel Dis. 2008 Jul 30. Smith PA.Nutritional therapy for active Crohn's disease. World J Gastroenterol. 2008 Jul 21;14(27):4420-3.Zvidi I, Hazazi R, Birkenfeld S, Niv Y. The Prevalence of Crohn's Disease in Israel: A 20-Year Survey. Dig Dis Sci. 2008 Jul 24. Butterworth AD, Thomas AG, Akobeng AK.Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006634. Review. Seow CH, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH.Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD000296. Review. Nguyen GC, Steinhart AH.Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality. Inflamm Bowel Dis. 2008 Jul 11. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G.Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2008 Jul 11. Jones J, Panaccione R.Biologic therapy in Crohn's disease: state of the art. Curr Opin Gastroenterol. 2008 Jul;24(4):475-81. Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF.Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet. 2008 Jul 5;372(9632):67-81. Review. Biancone L, Onali S, Calabrese E, Petruzziello C, Zorzi F, Condino G, Sica GS, Pallone F.Non-invasive techniques for assessing postoperative recurrence in Crohn's disease. Dig Liver Dis. 2008 Jul;40 Suppl 2:S265-70. Wiese DM, Rivera R, Seidner DL.Is there a role for bowel rest in nutrition management of Crohn's disease? Nutr Clin Pract. 2008 Jun-Jul;23(3):309-17. Palamaras I, El-Jabbour J, Pietropaolo N, Thomson P, Mann S, Robles W, Stevens H.Metastatic Crohn's disease: a review. J Eur Acad Dermatol Venereol. 2008 Jun 19 Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B.C -Reactive Protein: A Predictive Factor And Marker Of Inflammation In Inflammatory Bowel Disease Results From A Prospective Population-Based Study. Gut. 2008 Jun 19 Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF.Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol. 2008 Jun;6(6):644-53. Efthymiou A, Viazis N, Mantzaris G, Papadimitriou N, Tzourmakliotis D, Raptis S, Karamanolis DG.Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. Inflamm Bowel Dis. 2008 Jun 2. Hancock L, Beckly J, Geremia A, Cooney R, Cummings F, Pathan S, Guo C, Warren BF, Mortensen N, Ahmad T, Jewell D.Clinical and molecular characteristics of isolated colonic Crohn's disease. Inflamm Bowel Dis. 2008 Jun 2. Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, Tremaine WJ, Egan LJ, Faubion WA, Schroeder KW, Pardi DS, Hanson KA, Jewell DA, Barlow JM, Fidler JL, Huprich JE, Johnson CD, Harmsen WS, Zinsmeister AR, Sandborn WJ.Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc. 2008 Aug;68(2):255-66. Hadithi M, Cazemier M, Meijer GA, Bloemena E, Felt-Bersma RJ, Mulder CJ, Meuwissen SG, Pena AS, van Bodegraven AA.Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol. 2008 May 28;14(20):3183-7. Stengel JZ, Arnold HL.Is infliximab safe to use while breastfeeding? World J Gastroenterol. 2008 May 21;14(19):3085-7. Meuwis MA, Fillet M, Lutteri L, Marée R, Geurts P, de Seny D, Malaise M, Chapelle JP, Wehenkel L, Belaiche J, Merville MP, Louis E.Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clin Biochem. 2008 Aug;41(12):960-7. Gisbert JP, Niño P, Cara C, Rodrigo L.Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients. Aliment Pharmacol Ther. 2008 Jul;28(2):228-38. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, Baert F, Noman M, Vermeire S, Ternant D, Watier H, Paintaud G, Rutgeerts P.Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology. 2008 Jun;134(7):1861-8. Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK.Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2008 Jul;2(7):716-27. Angelberger S, Reinisch W, Dejaco C, Miehsler W, Waldhoer T, Wehkamp J, Lichtenberger C, Schaeffeler E, Vogelsang H, Schwab M, Teml A.NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease. Am J Gastroenterol. 2008 May;103(5):1197-202. Tinè F, Rossi F, Sferrazza A, Orlando A, Mocciaro F, Scimeca D, Olivo M, Cottone M.Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. Aliment Pharmacol Ther. 2008 Jun;27(12):1210-23. Matsumoto T, Iida M, Motoya S, Haruma K, Suzuki Y, Kobayashi K, Ito H, Miyata M, Kusunoki M, Chiba T, Yamamoto S, Hibi T.Therapeutic efficacy of infliximab on patients with short duration of Crohn's disease: a Japanese multicenter survey. Dis Colon Rectum. 2008 Jun;51(6):916-23. Leiper K, Martin K, Ellis A, Watson AJ, Morris AI, Rhodes JM.Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease. Aliment Pharmacol Ther. 2008 Jun;27(12):1233-9. Sokol H, Lay C, Seksik P, Tannock GW.Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis. 2008 Jun;14(6):858-67. Emanuel PO, Phelps RG.Metastatic Crohn's disease: a histopathologic study of 12 cases. J Cutan Pathol. 2008 May;35(5):457-61. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S.Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis. 2008 Jul;14(7):968-76. Kane SV, Reddy D.Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008 May;103(5):1193-6. Ripollés T, Martínez MJ, Barrachina MM.Crohn's disease and color Doppler sonography: response to treatment and its relationship with long-term prognosis. J Clin Ultrasound. 2008 Jun;36(5):267-72. Gal E, Geller A, Fraser G, Levi Z, Niv Y.Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI). Dig Dis Sci. 2008 Jul;53(7):1933-7. Del Vescovo R, Sansoni I, Caviglia R, Ribolsi M, Perrone G, Leoncini E, Grasso RF, Cicala M, Zobel BB.Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging. 2008 Jul-Aug;33(4):417-24. Desmond AN, O'Regan K, Curran C, McWilliams S, Fitzgerald T, Maher MM, Shanahan F. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008 Apr 29. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, Baert F, Noman M, Vermeire S, Ternant D, Watier H, Paintaud G, Rutgeerts P. Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial. Gastroenterology. 2008 Mar 8. Stasi C, Orlandelli E. Role of the brain-gut axis in the pathophysiology of Crohn's disease. Dig Dis. 2008;26(2):156-66.Benchimol E, Seow Ch, Steinhart A, Griffiths A. Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006792. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. m J Gastroenterol. 2008 May;103(5):1203-9.Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2008 Apr 10. Castiglione F, Bucci L, Pesce G, De Palma GD, Camera L, Cipolletta F, Testa A, Diaferia M, Rispo A. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis. 2008 Apr 8. Predicting Relapse in Crohn's Disease: A Biopsychosocial Model. Gut. 2008 Apr 7. Angelberger S, Reinisch W, Dejaco C, Miehsler W, Waldhoer T, Wehkamp J, Lichtenberger C, Schaeffeler E, Vogelsang H, Schwab M, Teml A. NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease. Am J Gastroenterol. 2008 May;103(5):1197-202. Colorectal cancer risk in Crohn's disease. World J Gastroenterol. 2008 Mar 28;14(12):1810-1. Tinè F, Rossi F, Sferrazza A, Orlando A, Mocciaro F, Scimeca D, Olivo M, Cottone M. Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. Aliment Pharmacol Ther. 2008 Jun;27(12):1210-23. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited? Gastroenterol Clin Biol. 2008 Feb;32(2):153-7. Benjamin J, Makharia GK, Ahuja V, Kalaivani M, Joshi YK. Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease. World J Gastroenterol. 2008 Mar 7;14(9):1399-405. Therapeutic Efficacy of Infliximab on Patients with Short Duration of Crohn's Disease: A Japanese Multicenter Survey. Dis Colon Rectum. 2008 Mar 6. Leiper K, Martin K, Ellis A, Watson AJ, Morris AI, Rhodes JM.Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease. Aliment Pharmacol Ther. 2008 Jun;27(12):1233-9. Anti-Inflammatory Role of Sympathetic Nerves in Chronic Intestinal Inflammation. Gut. 2008 Feb 28. D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A, Vermeire S, Van de Mierop FJ, Coche JC, van der Woude J, Ochsenkühn T, van Bodegraven AA, Van Hootegem PP, Lambrecht GL, Mana F, Rutgeerts P, Feagan BG, Hommes D; Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008 Feb 23;371(9613):660-7.Murphy SJ, Ullman TA, Abreu MT. Gut microbes in Crohn's disease: getting to know you better? Am J Gastroenterol. 2008 Feb;103(2):397-8. Sorrentino D. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? Digestion. 2008;77(1):38-47.Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice. J Clin Gastroenterol. 2008 Apr;42(4):395-9. Rahimi R, Nikfar S, Rahimi F, Elahi B, Derakhshani S, Vafaie M, Abdollahi M. A Meta-Analysis on the Efficacy of Probiotics for Maintenance of Remission and Prevention of Clinical and Endoscopic Relapse in Crohn's Disease. Dig Dis Sci. 2008 Feb 14.Eshuis EJ, Polle SW, Slors JF, Hommes DW, Sprangers MA, Gouma DJ, Bemelman WA. Long-Term Surgical Recurrence, Morbidity, Quality of Life, and Body Image of Laparoscopic-Assisted vs. Open Ileocolic Resection for Crohn's Disease: A Comparative Study. Dis Colon Rectum. 2008 Feb 12. Emanuel PO, Phelps RG. Metastatic Crohn's disease: a histopathologic study of 12 cases. J Cutan Pathol. 2008 May;35(5):457-61.Mottet C, Juillerat P, Pittet V, Gonvers JJ, Froehlich F, Vader JP, Michetti P, Felley C. Pregnancy and breastfeeding in patients with Crohn's disease.Digestion. 2007;76(2):149-60. Epub 2008 Feb 7. Review. Gonvers JJ, Juillerat P, Mottet C, Pittet V, Felley C, Vader JP, Michetti P, Froehlich F. Maintenance of medically induced remission of Crohn's disease. Digestion. 2007;76(2):116-29.Michetti P, Mottet C, Juillerat P, Pittet V, Felley C, Vader JP, Gonvers JJ, Froehlich F. Severe and steroid-resistant Crohn's disease. Digestion. 2007;76(2):99-108. Yip JS, Woodward M, Abreu MT, Sparrow MP. How are Azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice. Inflamm Bowel Dis. 2008 Apr;14(4):514-8. The use of adalimumab in the management of refractory Crohn's disease. Aliment Pharmacol Ther. 2008 Feb 15;27(4):308-15. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis. 2008 Feb;14(2):147-61.Kasparek MS, Glatzle J, Mueller MH, Schneider A, Koenigsrainer A, Kreis ME. Postoperative complications have little influence on long-term quality of life in Crohn's patients. J Gastrointest Surg. 2008 Mar;12(3):569-76. Schwandner O, Stadler F, Dietl O, Wirsching RP, Fuerst A. Initial experience on efficacy in closure of cryptoglandular and Crohn's transsphincteric fistulas by the use of the anal fistula plug. Int J Colorectal Dis. 2008 Mar;23(3):319-24. Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis.Inflamm Bowel Dis. 2008 Feb;14(2):213-6. Review. Lees CW, Maan AK, Hansoti B, Satsangi J, Arnott ID. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.Aliment Pharmacol Ther. 2008 Feb 1;27(3):220-7.Rudolph SJ, Weinberg DI, McCabe RP. Long-term durability of Crohn's disease treatment with infliximab. Dig Dis Sci. 2008 Apr;53(4):1033-41. Bartel G, Weiss I, Turetschek K, Schima W, Püspök A, Waldhoer T, Gasche C. Ingested matter affects intestinal lesions in Crohn's disease. Inflamm Bowel Dis. 2008 Mar;14(3):374-82.Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn's disease. Inflamm Bowel Dis. 2008 Feb;14(2):217-23. Graham DB, Tishon JR, Borum ML. An evaluation of vaginal symptoms in women with Crohn's disease. Dig Dis Sci. 2008 Mar;53(3):765-6.Mokrowiecka A, Gasiorowska A, Malecka-Panas E. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease. Hepatogastroenterology. 2007 Jul-Aug;54(77):1443-8. Ghoshal UC, Ghoshal U, Singh H, Tiwari S. Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India. J Postgrad Med. 2007 Jul-Sep;53(3):166-70. Minderhoud IM, Samsom M, Oldenburg B. What predicts mucosal inflammation in Crohn's disease patients? Inflamm Bowel Dis. 2007 Jul 30; Akobeng A, Thomas A. Enteral nutrition for maintenance of remission in Crohn's disease.Cochrane Database Syst Rev. 2007 Jul 18;(3): Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OO, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ; PRECISE 2 Study Investigators. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med. 2007 Jul 19;357(3):239-50. Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D, Bloomfield R, Schreiber S; PRECISE 1 Study Investigators. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med. 2007 Jul 19;357(3):228-38. Johnson FR, Ozdemir S, Mansfield C, Hass S, Miller DW, Siegel CA, Sands BE. Crohn's Disease Patients' Risk-Benefit Preferences: Serious Adverse Event Risks Versus Treatment Efficacy.Gastroenterology. 2007 May 3; East JE, Brooker JC, Rutter MD, Saunders BP. A Pilot Study of Intrastricture Steroid Versus Placebo Injection After Balloon Dilatation of Crohn's Strictures. Clin Gastroenterol Hepatol. 2007 Jul 10; Chrissafidou A, Malek M, Musch E. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease. Z Gastroenterol. 2007 Jul;45(7):605-8. Jones JL, Loftus EV Jr. Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment? Inflamm Bowel Dis. 2007 Jun 28; Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV. Dysplasia and Cancer in Inflammatory Bowel Disease 10 Years after Diagnosis: Results of a Population-Based European Collaborative Follow-Up Study. Digestion. 2007 Jun 26;75(2-3):113-121 Friedman S. Medical therapy and birth outcomes in women with Crohn's disease: what should we tell our patients? Am J Gastroenterol. 2007 Jul;102(7):1414-6. Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol. 2007 Sep;149(3):470-9. Van Kruiningen HJ, Joossens M, Vermeire S, Joossens S, Debeugny S, Gower-Rousseau C, Cortot A, Colombel JF, Rutgeerts P, Vlietinck R. Familial Crohn's disease in belgium: pedigrees, temporal relationships among cases, and family histories. J Clin Gastroenterol. 2007 Jul;41(6):583-90. Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease Activity in Pregnant Women With Crohn's Disease and Birth Outcomes: A Regional Danish Cohort Study. Am J Gastroenterol. 2007 Jun 15; Freeman HJ. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. Can J Gastroenterol. 2007 Jun;21(6):363-6. Casellas F, Rodrigo L, Nino P, Pantiga C, Riestra S, Malagelada JR. Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years. Inflamm Bowel Dis. 2007 Jun 13; Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am. 2007 Jun;87(3):575-85. Review. Keuchel M. Double balloon (push-and-pull) enteroscopy: breakthrough in the management of small intestinal strictures in Crohn's disease? Eur J Gastroenterol Hepatol. 2007 Jul;19(7):523-5. Sun B, Shen R, Cheng S, Zhang C, Zhong J. The role of double-balloon enteroscopy in diagnosis and management of incomplete small-bowel obstruction. Endoscopy. 2007 Jun;39(6):511-5. Steinhart AH, Forbes A, Mills EC, Rodgers-Gray BS, Travis SP. Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease. Aliment Pharmacol Ther. 2007 Jun 15;25(12):1389-99. Buxton MJ, Lacey LA, Feagan BG, Niecko T, Miller DW, Townsend RJ. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility. Value Health. 2007 May-Jun;10(3):214-20. Bernard A, Langille M, Hughes S, Rose C, Leddin D, Veldhuyzen van Zanten S. A Systematic Review of Patient Inflammatory Bowel Disease Information Resources on the World Wide Web. Am J Gastroenterol. 2007 May 19; Dhruva Rao PK, Davies M, Price PE, Torkington J. Crohn's disease: systematic review of assessment of disease severity and its relevance to surgery. Colorectal Dis. 2007 May 17; Torres MI, Lorite P, Lopez-Casado MA, Rios A. A new approach using tissue alkaline phosphatase histochemistry to identify Crohn's disease. Pathol Res Pract. 2007;203(6):485-7. Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J, Frisch M. The risk of developing Crohn's disease after an appendectomy: A population-based cohirt study in Sweden and Denmark. Gut. 2007 May 9; Targan SR, Feagan BG, Fedorak RN, Lashner BA, Panaccione R, Present DH, Spehlmann ME, Rutgeerts PJ, Tulassay Z, Volfova M, Wolf DC, Hernandez C, Bornstein J, Sandborn WJ; International Efficacy of Natalizumab in Crohn's Disease Response and Remission (ENCORE) Trial Group. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology. 2007 May;132(5):1672-83. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med. 2007 Jun 19;146(12):829-38. Henriksen M, Jahnsen J, Lygren I, Aadland E, Schulz T, Vatn MH, Moum B; the Ibsen Study Group. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007 May;42(5):602-10. Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol. 2007 Jul;102(7):1406-13. McHugh JB, Appelman HD, McKenna BJ. The diagnostic value of endoscopic terminal ileum biopsies. Am J Gastroenterol. 2007 May;102(5):1084-9. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum. 2007 Jun;50(6):839-55. Review. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007 Jun;56(6):830-7. Epub 2006 Dec 21. Review.
Targan SR, Feagan BG, Fedorak RN, Lashner BA, Panaccione R, Present
DH, Spehlmann ME, Rutgeerts PJ, Tulassay Z, Volfova M,
Wolf DC, Hernandez C, Bornstein J, Sandborn WJ;
International Efficacy of Natalizumab in Crohn's Disease
Response and Remission (ENCORE) Trial Group.
Natalizumab for the Treatment of Active Crohn's Disease:
Results of the ENCORE Trial. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF. Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab. A Randomized Trial. Ann Intern Med. 2007 Apr 30; Karban A, Eliakim R. Effect of smoking on inflammatory bowel disease: Is it disease or organ specific? World J Gastroenterol. 2007 Apr 21;13(15):2150-2.
Papp M, Norman
GL, Altorjay I, Lakatos PL.
Utility of serological markers in inflammatory bowel
diseases: Gadget or magic?
Nuding S,
Fellermann K, Wehkamp J, Stange EF.
Reduced mucosal antimicrobial activity in Crohn's
disease of the colon. Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman G, Altstock R, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007 Apr 24; Kuhbacher T, Folsch UR. Practical guidelines for the treatment of inflammatory bowel disease. World J Gastroenterol. 2007 Feb 28;13(8):1149-55. Rodgers AD, Cummins AG. CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn's Disease. Dig Dis Sci. 2007 Apr 11;
Guessous I,
Juillerat P, Pittet V, Froehlich F, Burnand B, Mottet C,
Felley C, Michetti P, Vader JP.
Evaluating appropriateness of treatment for Crohn's
disease: feasibility of an explicit approach. Park CH, Kim JO, Choi MG, Kim KJ, Kim YH, Kim YS, Kim TI, Do JH, Ryu JK, Moon JS, Park SH, Shim KN, Lee KM, Lee IS, Chun HJ. Utility of capsule endoscopy for the classification of Crohn's disease: a multicenter study in Korea. Dig Dis Sci. 2007 Jun;52(6):1405-9. Canavan C, Abrams KR, Mayberry JF. Meta-analysis: mortality in Crohn's disease. Aliment Pharmacol Ther. 2007 Apr 15;25(8):861-70. Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M; the Study Group for Inflammatory Bowel Diseases GSMII. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol. 2007 Apr;22(4):542-9. Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut. 2007 Apr;56(4):453-5. Review. Picco MF. New studies on the role of smoking in inflammatory bowel disease: are we not beating a dead horse? Am J Gastroenterol. 2007 Mar;102(3):598-600.
Hyams J,
Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns
J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S,
Winter H, Veereman-Wauters G, Ferry G, Baldassano R;
REACH Study Group.
Induction and maintenance infliximab therapy for the
treatment of moderate-to-severe Crohn's disease in
children.
von Roon AC,
Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP.
The Risk of Cancer in Patients with Crohn's Disease. Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study. J Gastroenterol Hepatol. 2007 Feb;22(2):268-74.
Smith JP,
Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS.
Low-dose naltrexone therapy improves active Crohn's
disease. Papi C, Festa V, Leandro G, Moretti A, Tanga M, Koch M, Capurso L. Long-term outcome of Crohn's disease following corticosteroid-induced remission. Am J Gastroenterol. 2007 Apr;102(4):814-9. Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen OO, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007 Apr;13(4):481-9. Ng SC, Arebi N, Kamm MA. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Inflamm Bowel Dis. 2007 Feb;13(2):129-34.
Mantzaris GJ, Roussos A,
Kalantzis C, Koilakou S, Raptis N, Kalantzis
N.
How adherent to treatment with azathioprine are patients
with Crohn's disease in long-term remission? Dorn SD, Sandler RS. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol. 2007 Mar;102(3):662-7. Review. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease. Clin Ther. 2006 Dec;28(12):1983-8.
Wu F,
Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML,
Bayless TM, Parmigiani G, Chakravarti S.
Genome-wide gene expression differences in Crohn's
disease and ulcerative colitis from endoscopic pinch
biopsies: Insights into distinctive pathogenesis.
Inflamm Bowel Dis. 2007 Jan 29;
Spoettl T, Hausmann M, Klebl F, Dirmeier A, Klump B, Hoffmann J, Herfarth H, Timmer A, Rogler G. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients. Inflamm Bowel Dis. 2007 Jan 26; Macdonald J, McDonald J. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097.
Zachos
M, Tondeur M, Griffiths A.
Enteral nutritional therapy for induction of remission
in Crohn's disease. Abubakar I, Myhill DJ, Hart AR, Lake IR, Harvey I, Rhodes JM, Robinson R, Lobo AJ, Probert CS, Hunter PR. A Case-Control Study of Drinking Water and Dairy Products in Crohn's Disease--Further Investigation of the Possible Role of Mycobacterium avium paratuberculosis. Am J Epidemiol. 2007 Jan 19; Vermeire S, Noman M, van Assche G, Baert F, D'Haens G, Rutgeerts PJ. The effectiviness of concomitant immunosuppressive therapy to suppress formation of antibodies to infliximab in crohn's disease. Gut. 2007 Jan 17; Canavan C, Abrams KR, Hawthorne B, Mayberry JF. Long-term prognosis in Crohn's disease: An epidemiological study of patients diagnosed more than 20 years ago in Cardiff. Aliment Pharmacol Ther. 2007 Jan 1;25(1):59-65. Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-Dose Naltrexone Therapy Improves Active Crohn's Disease. Am J Gastroenterol. 2007 Jan 11;
Papi C,
Festa V, Leandro G, Moretti A, Tanga M, Koch M, Capurso
L.
Long-Term Outcome of Crohn's Disease Following
Corticosteroid-Induced Remission. Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen OO, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: A population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2006 Dec 19;
Dassopoulos T, Frangakis C, Cruz-Correa M, Talor MV,
Burek CL, Datta L, Nouvet F, Bayless TM, Brant SR.
Antibodies to Saccharomyces cerevisiae in Crohn's
disease: Higher titers are associated with a greater
frequency of mutant NOD2/CARD15 alleles and with a
higher probability of complicated disease.
Mahid
SS, Minor KS, Stromberg AJ, Galandiuk S.
Active and passive smoking in childhood is related to
the development of inflammatory bowel disease. Mantzaris GJ, Roussos A, Kalantzis C, Koilakou S, Raptis N, Kalantzis N. How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission? Inflamm Bowel Dis. 2006 Dec 19;
Joossens M, Simoens M, Vermeire S, Bossuyt X, Geboes K,
Rutgeerts P.
Contribution of genetic and environmental factors in the
pathogenesis of Crohn's disease in a large family with
multiple cases. Sands BE, Kozarek R, Spainhour J, Barish CF, Becker S, Goldberg L, Katz S, Goldblum R, Harrigan R, Hilton D, Hanauer SB. Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab. Inflamm Bowel Dis. 2007 Jan;13(1):2-11. Masunaga Y, Ohno K, Ogawa R, Hashiguchi M, Echizen H, Ogata H. Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother. 2007 Jan;41(1):21-8. Girelli CM, Porta P, Malacrida V, Barzaghi F, Rocca F. Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn's disease. Dig Liver Dis. 2007 Feb;39(2):148-54. Korzenik JR. Is Crohn's disease due to defective immunity? Gut. 2007 Jan;56(1):2-5. Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci. 2007 Jan;52(1):33-9. Dorn SD, Sandler RS. Inflammatory Bowel Disease Is Not a Risk Factor for Cardiovascular Disease Mortality: Results from a Systematic Review and Meta-Analysis. Am J Gastroenterol. 2006 Dec 11;
Radford-Smith G, Pandeya N.
Associations between NOD2/CARD15 genotype and phenotype
in Crohn's disease--Are we there yet? World J
Gastroenterol. 2006 Nov 28;12(44):7097-103.
Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D,
Garcia-Gil LJ.
Abnormal microbiota composition in the ileocolonic
mucosa of Crohn's disease patients as revealed by
polymerase chain reaction-denaturing gradient gel
electrophoresis. Seiderer J, Schnitzler F, Brand S, Staudinger T, Pfennig S, Herrmann K, Hofbauer K, Dambacher J, Tillack C, Sackmann M, Goke B, Lohse P, Ochsenkuhn T. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol. 2006 Dec;41(12):1421-32. Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R, Salomez JL, Hellot MF, Dupas JL, Colombel JF, Cortot A, Benichou J. Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol. 2007 Jan;102(1):122-31. Sido B, Seel C, Hochlehnert A, Breitkreutz R, Droge W. Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation? Dig Dis Sci. 2006 Dec;51(12):2170-9. May A, Ell C. Push-and-pull enteroscopy using the double-balloon technique/double-balloon enteroscopy. Dig Liver Dis. 2006 Dec;38(12):932-8. Oostenbrug LE, Nolte IM, Oosterom E, van der Steege G, te Meerman GJ, van Dullemen HM, Drenth JP, de Jong DJ, van der Linde K, Jansen PL, Kleibeuker JH. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis. Dig Liver Dis. 2006 Nov;38(11):834-45. Esaki M, Matsumoto T, Nakamura S, Yada S, Fujisawa K, Jo Y, Iida M. Factors affecting recurrence in patients with Crohn's disease under nutritional therapy. Dis Colon Rectum. 2006 Oct;49 Suppl 1:S68-74.Ng V, Millard W, Lebrun C, Howard J. Exercise and Crohn's disease: speculations on potential benefits. Can J Gastroenterol. 2006 Oct;20(10):657-60.Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004826. Review.Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C, Binder V, Jarnerot G. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis. 2006 Oct;12(10):925-33.Steenhagen E, de Roos NM, Bouwman CA, van Laarhoven CJ, van Staveren WA. Sources and severity of self-reported food intolerance after ileal pouch-anal anastomosis. J Am Diet Assoc. 2006 Sep;106(9):1459-62. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease. Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:90-5. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut. 2006 Sep 6;Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol. 2006 Oct;21(10):1609-14. Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients. Dig Dis Sci. 2006 Sep;51(9):1516-24.Baichi MM, Arifuddin RM, Mantry PS. What we have learned from 5 cases of permanent capsule retention. Gastrointest Endosc. 2006 Aug;64(2):283-7.Cheifetz AS, Kornbluth AA, Legnani P, Schmelkin I, Brown A, Lichtiger S, Lewis BS. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease.Am J Gastroenterol. 2006 Oct;101(10):2218-22. Biagi F, Rondonotti E, Campanella J, Villa F, Bianchi PI, Klersy C, De Franchis R, Corazza GR. Video capsule endoscopy and histology for small-bowel mucosa evaluation: a comparison performed by blinded observers. Clin Gastroenterol Hepatol. 2006 Aug;4(8):998-1003. |
